# EDGAR Filing Document

**Accession Number:** 0001732710
**File Stem:** 0001872856-26-000134
**Filing Date:** 2026-4
**Character Count:** 3270
**Document Hash:** f78daf3c383d180683be6af7e849cd8a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001872856-26-000134.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001872856-26-000134

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260429

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TriAgenics, Inc
- **CENTRAL INDEX KEY:** 0001732710

**ORGANIZATION NAME:**
- **EIN:** 461753757
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-32434
- **FILM NUMBER:** 26911633

**BUSINESS ADDRESS:**
- **STREET 1:** 525 SW UMATILLA AVENUE
- **STREET 2:** SUITE 102
- **CITY:** REDMOND
- **STATE:** OR
- **ZIP:** 97756
- **BUSINESS PHONE:** 541-527-1800

**MAIL ADDRESS:**
- **STREET 1:** 525 SW UMATILLA AVE
- **STREET 2:** SUITE 102
- **CITY:** REDMOND
- **STATE:** OR
- **ZIP:** 97656

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Triagenics Inc
- **DATE OF NAME CHANGE:** 20180226

### Attached PDF Documents

**Attachment 1:** `triagenicscar.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** TriAgenics, Inc

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 09-22-2017

**Physical Address:** 525 SW UMATILLA AVE, REDMOND, OR, 97656

**Issuer Website:** www.TriAgenics.com

**Is there a Co-Issuer?:** Yes

### Annual Report Disclosure Requirements

**Current Number of Employees:** 3.00

**Total Assets (Most Recent Fiscal Year):** $3,246,152.00

**Total Assets (Prior Fiscal Year):** $1,290,005.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $3,045,890.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $976,252.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $160,614.00

**Short-Term Debt (Prior Fiscal Year):** $159,014.00

**Long-Term Debt (Most Recent Fiscal Year):** $0.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $0.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $-410.00

**Taxes Paid (Prior Fiscal Year):** $2,433.00

**Net Income (Most Recent Fiscal Year):** $-2,242,946.00

**Net Income (Prior Fiscal Year):** $-2,183,070.00

### Signatures

**Issuer:** TriAgenics, Inc

**Signature:** David Thrower

**Title:** Chief Executive Officer

---

**Signature:** Leigh Colby

**Title:** Director

**Date:** 04-29-2026

---

**Signature:** David Thrower

**Title:** Director

**Date:** 04-29-2026

---

**Signature:** Dave Watson

**Title:** Director

**Date:** 04-29-2026

---

**Signature:** John Joseph Chopack, Jr

**Title:** Director

**Date:** 04-29-2026

---

**Signature:** Jeffrey Miles Jacobs

**Title:** Director

**Date:** 04-29-2026

---

**Signature:** David Jahns

**Title:** Director

**Date:** 04-29-2026